Messager M, Carrière C, Bertagna X, de Keyzer Y
Institut Cochin, INSERM U567-CNRS UMR8107, 24 rue du faubourg Saint Jacques, 75014, Paris, France.
Eur J Endocrinol. 2006 Jan;154(1):159-66. doi: 10.1530/eje.1.02077.
ACTH is frequently produced in non-pituitary tumours, leading to the ectopic-ACTH syndrome, but the molecular mechanisms of its expression remain obscure. This study was aimed at understanding the transcription mechanisms of the ACTH-precursor gene in carcinoid tumours of the lung or thymus.
Transcripts coding for a series of corticotroph-associated transcription factor genes were detected, together with markers of the corticotroph phenotype. We studied a series of 41 carcinoid tumours including 15 with proven ectopic-ACTH syndrome.
Specific RT-PCR reactions were designed for each gene including alternatively spliced isoforms.
The markers of the corticotroph phenotype were detected in all ACTH-positive tumours. Expression of the Tpit and Pitx1 genes were not restricted to ACTH-positive tumours but were also detected in many ACTH-negative carcinoids. Only a subset of ACTH-negative tumours expressed NAK-1/Nur77, and NeuroD1 expression was detected in approximately 50% of the tumours regardless of their secretory status. The glucocorticoid receptor alpha was detected in every tumour in contrast to its beta isoform detectable in a few tumours only. Chicken ovalbumin upstream promoter-transcription factor 1 (COUP-TF1) and peroxisome proliferator-activated receptor (PPAR) gamma2 were expressed in 50% of the tumours of each group whereas PPARgamma1 was expressed in almost every tumour.
ACTH-positive carcinoids do not share a characteristic expression pattern of the corticotroph-associated transcription factor genes, suggesting that the transcriptional mechanisms of the ACTH-precursor gene differ from those in normal pituitary corticotrophs. Expression of Tpit and Pitx1 genes in most carcinoids suggests that some aspects of the pituitary corticotroph phenotype may belong to general carcinoid differentiation.
促肾上腺皮质激素(ACTH)常由非垂体肿瘤产生,导致异位ACTH综合征,但其表达的分子机制仍不清楚。本研究旨在了解肺或胸腺类癌肿瘤中ACTH前体基因的转录机制。
检测编码一系列促肾上腺皮质激素相关转录因子基因的转录本以及促肾上腺皮质激素表型的标志物。我们研究了41例类癌肿瘤,其中15例证实有异位ACTH综合征。
针对每个基因设计特异性逆转录聚合酶链反应(RT-PCR),包括可变剪接异构体。
在所有ACTH阳性肿瘤中均检测到促肾上腺皮质激素表型的标志物。Tpit和Pitx1基因的表达不仅限于ACTH阳性肿瘤,在许多ACTH阴性类癌中也可检测到。只有一部分ACTH阴性肿瘤表达NAK-1/Nur77,无论其分泌状态如何,约50%的肿瘤中可检测到NeuroD1的表达。与仅在少数肿瘤中可检测到的β异构体相比,每个肿瘤中均检测到糖皮质激素受体α。每组50%的肿瘤中表达鸡卵清蛋白上游启动子转录因子1(COUP-TF1)和过氧化物酶体增殖物激活受体(PPAR)γ2,而几乎每个肿瘤中都表达PPARγ1。
ACTH阳性类癌不具有促肾上腺皮质激素相关转录因子基因的特征性表达模式,提示ACTH前体基因的转录机制与正常垂体促肾上腺皮质细胞不同。大多数类癌中Tpit和Pitx1基因的表达表明垂体促肾上腺皮质激素表型的某些方面可能属于一般类癌分化。